Processing

Please wait...

Settings

Settings

Goto Application

1. WO2021159130 - CORONAVIRUS RNA VACCINES AND METHODS OF USE

Publication Number WO/2021/159130
Publication Date 12.08.2021
International Application No. PCT/US2021/032609
International Filing Date 14.05.2021
IPC
A61K 39/215 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39Medicinal preparations containing antigens or antibodies
12Viral antigens
215Coronaviridae, e.g. avian infectious bronchitis virus
CPC
A61K 2039/53
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39Medicinal preparations containing antigens or antibodies
51comprising whole cells, viruses or DNA/RNA
53DNA (RNA) vaccination
A61K 2039/545
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39Medicinal preparations containing antigens or antibodies
545characterised by the dose, timing or administration schedule
A61K 2039/55555
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39Medicinal preparations containing antigens or antibodies
555characterised by a specific combination antigen/adjuvant
55511Organic adjuvants
55555Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
A61K 2039/57
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39Medicinal preparations containing antigens or antibodies
57characterised by the type of response, e.g. Th1, Th2
A61K 2039/572
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39Medicinal preparations containing antigens or antibodies
57characterised by the type of response, e.g. Th1, Th2
572cytotoxic response
A61K 2039/575
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39Medicinal preparations containing antigens or antibodies
57characterised by the type of response, e.g. Th1, Th2
575humoral response
Applicants
  • MODERNATX, INC. [US]/[US]
  • THE UNITED STATES OF AMERICA, as represented by THE DEPARTMENT OF HEALTH AND HUMAN SERVICES [US]/[US]
Inventors
  • BENNETT, Hamilton
  • STEWART-JONES, Guillaume
  • NARAYANAN, Elisabeth
  • CARFI, Andrea
  • METKAR, Mihir
  • PRESNYAK, Vladimir
  • GRAHAM, Barney S.
  • CORBETT, Kizzmekia S.
Agents
  • LOCKHART, Helen C.
  • ATTISHA, Michael, J.
  • VON REYN, Jessica, A.
  • LOCKHART, Helen, C.
  • ALAM, Saad
Priority Data
63/025,91815.05.2020US
63/028,42421.05.2020US
Publication Language English (en)
Filing Language English (EN)
Designated States
Title
(EN) CORONAVIRUS RNA VACCINES AND METHODS OF USE
(FR) VACCINS A ARN DE CORONAVIRUS ET PROCÉDÉS D'UTILISATION
Abstract
(EN) The disclosure relates to SARS-CoV-2 messenger ribonucleic acid (mRNA) vaccine compositions as well as methods of using the vaccines.
(FR) L'invention concerne des compositions de vaccins à acide ribonucléique messager (ARNm) de SARS-CoV-2, ainsi que des méthodes d'utilisation des vaccins.
Latest bibliographic data on file with the International Bureau